PMID- 38492186 OWN - NLM STAT- Publisher LR - 20240316 IS - 1573-2576 (Electronic) IS - 0360-3997 (Linking) DP - 2024 Mar 16 TI - Immunomodulatory and Anti-Inflammatory Effects of Vitamin A and Tryptophan on Monocyte-Derived Dendritic Cells Stimulated with Gliadin in Celiac Disease Patients. LID - 10.1007/s10753-024-02004-7 [doi] AB - Celiac Disease (CeD) is an autoimmune disorder with various symptoms upon gluten exposure. Dendritic cells (DCs) play a crucial role in gliadin-induced inflammation. Vitamin A (retinol; Ret) and its metabolite, retinoic acid (RA), along with tryptophan (Trp) and its metabolite, kynurenic acid (KYNA), are known to influence the immune function of DCs and enhance their tolerogenicity. This research aims to assess the impact of gliadin on DC maturation and the potential of vitamin A and tryptophan to induce immune tolerance in DCs. The monocyte cells obtained from peripheral blood mononuclear cells (PBMCs) of celiac disease patients were differentiated into DCs in the absence or presence of Ret, RA, Trp, KYNA, and then stimulated with peptic and tryptic (PT) digested of gliadin. We used flow cytometry to analyze CD11c, CD14, HLA-DR, CD83, CD86, and CD103 expression. ELISA was carried out to measure TGF-beta, IL-10, IL-12, and TNF-alpha levels. qRT-PCR was used to assess the mRNA expression of retinaldehyde dehydrogenase 2 (RALDH2) and integrin alphaE (CD103). The mRNA and protein levels of Indoleamine 2, 3-dioxygenase (IDO) was analyzed by qRT-PCR and Western blot assays, respectively. Our findings demonstrate that PT-gliadin enhances the expression of maturation markers, i.e. CD83, CD86 and HLA-DR and promote the secretion of TNF-alpha and IL-12 in DCs. Interestingly, vitamin A, tryptophan, and their metabolites increase the expression of CD103, while limiting the expression of HLA-DR, CD83, and CD86. They also enhance RALDH2 and IDO expression and promote the secretion of TGF-beta and IL-10, while limiting IL-12 and TNF-alpha secretion. These findings suggest that vitamin A and tryptophan have beneficial effects on PT-gliadin-stimulated DCs, highlighting their potential as therapeutic agents for celiac disease. However, further research is needed to fully understand their underlying mechanisms of action in these cells. CI - (c) 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Asgari, Fatemeh AU - Asgari F AD - Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. AD - Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. FAU - Nikzamir, Abdolrahim AU - Nikzamir A AD - Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. FAU - Baghaei, Kaveh AU - Baghaei K AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. FAU - Salami, Siamak AU - Salami S AD - Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. FAU - Masotti, Andrea AU - Masotti A AD - Bambino Gesu Children's Hospital-IRCCS, Research Laboratories, V.le San Paolo 15, 00146, Rome, Italy. FAU - Rostami-Nejad, Mohammad AU - Rostami-Nejad M AD - Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. m.rostamii@sbmu.ac.ir. LA - eng PT - Journal Article DEP - 20240316 PL - United States TA - Inflammation JT - Inflammation JID - 7600105 SB - IM OTO - NOTNLM OT - 3-dioxygenase OT - Celiac disease OT - Dendritic cells OT - Immune tolerance. OT - Indoleamine 2 OT - Tryptophan OT - Vitamin A EDAT- 2024/03/16 21:47 MHDA- 2024/03/16 21:47 CRDT- 2024/03/16 12:21 PHST- 2023/12/12 00:00 [received] PHST- 2024/03/04 00:00 [accepted] PHST- 2024/02/29 00:00 [revised] PHST- 2024/03/16 21:47 [medline] PHST- 2024/03/16 21:47 [pubmed] PHST- 2024/03/16 12:21 [entrez] AID - 10.1007/s10753-024-02004-7 [pii] AID - 10.1007/s10753-024-02004-7 [doi] PST - aheadofprint SO - Inflammation. 2024 Mar 16. doi: 10.1007/s10753-024-02004-7.